Aigen Investment Management, LP Ardelyx, Inc. Transaction History

Aigen Investment Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$5.28 - $7.57 $28,226 - $40,469	5,346 Added 29.43%	23,510 $161,000
Q2 2024 Aug 09, 2024	SELL	$5.89 - $9.31 $320,516 - $506,622	-54,417 Reduced 74.97%	18,164 $134,000
Q1 2024 May 14, 2024	BUY	$6.05 - $9.74 $439,115 - $706,938	72,581 New	72,581 $529,000

233

150M

1.54M

3.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $779M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.